Navigation Links
Mauna Kea Technologies Announces Strong Presence of Cellvizio Platform at Major Medical Meetings Focused on Gastroenterology
Date:5/19/2016

PARIS, May 19,2016 /PRNewswire/ --

Cellvizio Highlighted in Physician Presentations and Company Activities at Digestive Disease Week Meeting and 91st Congress of the Japan Gastroenterological Endoscopy Society

Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, today announced that its Cellvizio platform is being highlighted at two major medical meeting focused on gastroenterology during the month of May. The first meeting highlighting Cellvizio is Digestive Disease Week (DDW) 2016, which is being held May 21-24, 2016 in San Diego, CA. DDW is the world's largest gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy, and gastrointestinal surgery.

Cellvizio will be featured in 28 poster presentations and 11 oral presentations by leading physicians during the DDW meeting, a strong progression with respect to last year. In addition, at its booth (#1218), Mauna Kea will be highlighting the use of Cellvizio confocal laser endomicroscopy (CLE) in the surveillance and treatment of Barrett's Esophagus, which is a primary risk factor for developing esophageal cancer, and in the characterization of pancreatic lesions and biliary strictures.

Sacha Loiseau, Ph.D., Co-Founder and CEO of Mauna Kea Technologies, declared, "This year's DDW meeting promises to be a significant opportunity to highlight the Cellvizio platform to leading gastroenterologists from around the world, with a high number of presentations in key therapeutic areas. The use of our needle-based Cellvizio platform for the characterization of pancreatic lesions is rapidly becoming a method of choice for interventional endoscopists and we look forward to the communications around our CONTACT II 200-patient study in the following months."

The second meeting highlighting Cellvizio is the 91st Congress of the Japan Gastroenterological Endoscopy Society (JGES), which was held May 12-14, 2016 in Tokyo, Japan. The goals of the JGES are to promote fundamental and clinical research in the field of gastroenterological endoscopy and to contribute to improvements in human healthcare in Japan and worldwide through academic research. At the meeting, Cellvizio was featured in 10 physician presentations and during a dedicated luncheon seminar with more than 300 attendees.

About Mauna Kea Technologies 
Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer thanks to real time in vivo microscopic visualization. The Company's flagship product, Cellvizio, has received clearance to sell a wide range of applications in more than 40 countries, including the United States, Europe, Japan, China, Canada, Brazil and Mexico.

For more information on Mauna Kea Technologies, visit www.maunakeatech.com

Mauna Kea Technologies Benoit Jacheet CFO investors@maunakeatech.com United States Zack Kubow / Lee Roth The Ruth Group 646-536-7020 / 7012 zkubow@theruthgroup.com lroth@theruthgroup.com U.S. Media Christopher Hippolyte The Ruth Group 646-536-7023 chippolyte@theruthgroup.com France and Europe NewCap - Investor Relations Florent Alba +33 (0)1 44 71 94 94 maunakea@newcap.fr

This is a disclosure announcement from PR Newswire.


'/>"/>
SOURCE Mauna Kea Technologies
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Mauna Kea Technologies Cellvizio Featured Prominently at 2016 World Congress for Bronchology and Interventional Pulmonology
2. Mauna Kea Technologies Announces Cook Medicals Introduction of the Cellvizio Platform at the American Urological Association Annual Meeting
3. Mauna Kea Technologies : chiffre daffaires T1 2016 et bilan dactivité
4. Mauna Kea Technologies Reports First Quarter 2016 Sales and Provides Business Update
5. Edinburgh Molecular Imaging and Mauna Kea Technologies Announce Clinical Molecular Imaging Collaboration
6. MAUNA KEA TECHNOLOGIES ANNONCE SES RESULTATS 2015
7. Mauna Kea Technologies Announces its FY 2015 Results
8. Mauna Kea Technologies Completes Enrollment of 200 Patient Contact II Study on Characterization of Pancreatic Cysts with Needle-Based Confocal Laser Endomicroscopy
9. Mauna Kea Technologies Announces Expanded Strategic Multiyear Partnership With Fujifilm China
10. Mauna Kea Technologies Announces the Appointment of Joseph DeVivo as a Non-Executive Director
11. MAUNA KEA TECHNOLOGIES ANNONCE SON AGENDA FINANCIER 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers ... companies have a waiver for care if the client has a cognitive impairment diagnosis. ... pays for care, is often waived, so the benefits from their insurance start immediately,” ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
Breaking Medicine News(10 mins):